20
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Reversibility of Inhibition of DNA Double Strand Break Repair by 2-Deoxy-d-Glucose in Ehrlich Ascites Tumour Cells

&
Pages 459-467 | Received 03 Aug 1992, Accepted 04 Dec 1992, Published online: 03 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

R Varshney, BS Dwarakanath & V Jain. (2005) Radiosensitization by 6-aminonicotinamide and 2-deoxy-D-glucose in human cancer cells. International Journal of Radiation Biology 81:5, pages 397-408.
Read now

Articles from other publishers (11)

Simran Chopra, Aditya Dahiya, Ashrit Nair, Navneet Sharma & Rakesh Kumar Sharma. 2023. Drug Repurposing for Emerging Infectious Diseases and Cancer. Drug Repurposing for Emerging Infectious Diseases and Cancer 479 500 .
Rani Zananiri, Sivasubramanyan Mangapuram Venkata, Vera Gaydar, Dan Yahalom, Omri Malik, Sergei Rudnizky, Oded Kleifeld, Ariel Kaplan & Arnon Henn. (2022) Auxiliary ATP binding sites support DNA unwinding by RecBCD. Nature Communications 13:1.
Crossref
Richa Bhardwaj, Pradeep K. Sharma, S. P. S. Jadon & Rajeev Varshney. (2012) A combination of 2-deoxy-d-glucose and 6-aminonicotinamide induces cell cycle arrest and apoptosis selectively in irradiated human malignant cells. Tumor Biology 33:4, pages 1021-1030.
Crossref
Nicholas C. Denko. (2008) Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nature Reviews Cancer 8:9, pages 705-713.
Crossref
Divya Khaitan, Sudhir Chandna, MB Arya & BS Dwarakanath. (2006) Establishment and characterization of multicellular spheroids from a human glioma cell line; Implications for tumor therapy. Journal of Translational Medicine 4:1.
Crossref
R Varshney, S Gupta & B S Dwarakanath. (2016) Radiosensitization of Murine Ehrlich Ascites Tumor by a Combination of 2-deoxy-D-Glucose and 6-Aminonicotinamide. Technology in Cancer Research & Treatment 3:6, pages 659-663.
Crossref
Laurent SchwartzLaurent Schwartz. 2004. Cancer — Between Glycolysis and Physical Constraint. Cancer — Between Glycolysis and Physical Constraint 135 144 .
Bilikere S Dwarkanath, Frido Zolzer, Sudhir Chandana, Thomas Bauch, Jawahar S Adhikari, Wolfgang U Muller, Christian Streffer & Viney Jain. (2001) Heterogeneity in 2-deoxy-D-glucose–induced modifications in energetics and radiation responses of human tumor cell lines. International Journal of Radiation Oncology*Biology*Physics 50:4, pages 1051-1061.
Crossref
Anke B. Binder, Antonio M. Serafin & Lothar J. F. Bohm. (2000) Abrogation of G 2 /M-Phase Block Enhances the Cytotoxicity of Daunorubicin, Melphalan and Cisplatin in TP53 Mutant Human Tumor Cells . Radiation Research 154:6, pages 640-649.
Crossref
B.S Dwarakanath, J.S Adhikari & Viney Jain. (1999) Hematoporphyrin derivatives potentiate the radiosensitizing effects of 2-deoxy-D-glucose in cancer cells. International Journal of Radiation Oncology*Biology*Physics 43:5, pages 1125-1133.
Crossref
Bidhu K. Mohanti, Goura K. Rath, Naranappa Anantha, V. Kannan, Bhabani S. Das, Bangalore A.R. Chandramouli, Ajit K. Banerjee, Sarala Das, Amarnath Jena, Ramamurthy Ravichandran, Uday P. Sahi, Rajinder Kumar, Neeru Kapoor, Vijay K. Kalia, Bilikere S. Dwarakanath & Viney Jain. (1996) Improving cancer radiotherapy with 2-deoxy-d-glucose: phase I/II clinical trials on human cerebral gliomas. International Journal of Radiation Oncology*Biology*Physics 35:1, pages 103-111.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.